1. Home
  2. TNXP vs WHLM Comparison

TNXP vs WHLM Comparison

Compare TNXP & WHLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNXP
  • WHLM
  • Stock Information
  • Founded
  • TNXP 2007
  • WHLM 1967
  • Country
  • TNXP United States
  • WHLM United States
  • Employees
  • TNXP N/A
  • WHLM N/A
  • Industry
  • TNXP Biotechnology: Pharmaceutical Preparations
  • WHLM Professional Services
  • Sector
  • TNXP Health Care
  • WHLM Consumer Discretionary
  • Exchange
  • TNXP Nasdaq
  • WHLM Nasdaq
  • Market Cap
  • TNXP 19.5M
  • WHLM 16.9M
  • IPO Year
  • TNXP N/A
  • WHLM 1996
  • Fundamental
  • Price
  • TNXP $0.19
  • WHLM $3.90
  • Analyst Decision
  • TNXP Strong Buy
  • WHLM
  • Analyst Count
  • TNXP 2
  • WHLM 0
  • Target Price
  • TNXP $53.50
  • WHLM N/A
  • AVG Volume (30 Days)
  • TNXP 51.5M
  • WHLM 75.2K
  • Earning Date
  • TNXP 11-12-2024
  • WHLM 11-13-2024
  • Dividend Yield
  • TNXP N/A
  • WHLM N/A
  • EPS Growth
  • TNXP N/A
  • WHLM 22.22
  • EPS
  • TNXP N/A
  • WHLM 0.11
  • Revenue
  • TNXP $11,291,000.00
  • WHLM $17,094,000.00
  • Revenue This Year
  • TNXP $62.53
  • WHLM N/A
  • Revenue Next Year
  • TNXP $26.17
  • WHLM N/A
  • P/E Ratio
  • TNXP N/A
  • WHLM $33.45
  • Revenue Growth
  • TNXP 183.05
  • WHLM N/A
  • 52 Week Low
  • TNXP $0.12
  • WHLM $3.02
  • 52 Week High
  • TNXP $22.08
  • WHLM $7.62
  • Technical
  • Relative Strength Index (RSI)
  • TNXP 69.43
  • WHLM 55.14
  • Support Level
  • TNXP $0.13
  • WHLM $3.17
  • Resistance Level
  • TNXP $0.28
  • WHLM $3.74
  • Average True Range (ATR)
  • TNXP 0.02
  • WHLM 0.27
  • MACD
  • TNXP 0.01
  • WHLM 0.08
  • Stochastic Oscillator
  • TNXP 49.47
  • WHLM 81.48

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

About WHLM Wilhelmina International Inc.

Wilhelmina International Inc is engaged in the business of fashion model management. The company provides traditional, full-service fashion model and talent management services, specializing in the representation and management of models, entertainers, artists, athletes and another talent to various clients which include retailers, designers, advertising agencies, print and electronic media and catalog companies. In addition, the company is also engaged in providing fashion modeling and talent product endorsement services to clients such as advertising agencies, branded consumer goods companies, fashion designers, magazine publications, retailers, department stores, product catalogs and Internet sites.

Share on Social Networks: